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Abstract
Background: Fetal macrosomia is defined as birth weight ≥4000 g. Several risk factors have been shown to be
associated with fetal macrosomia. There has been an increased incidence of macrosomic babies delivered and the
antecedent complications.
This study assessed the risk factors, maternal and neonatal complications of fetal macrosomia in comparison with
normal birth weight neonates.
Methods: A case-control study was conducted at the Muhimbili National Hospital (MNH) maternity and neonatal
wards. Cases comprised of neonates with birth weight ≥4000 g; controls were matched for sex and included
neonates weighing 2500–3999 g. Detailed clinical and demographic information and laboratory investigations
which included blood glucose, hematocrit and plasma calcium were collected. The child was followed up to
discharge/death.
Results: The prevalence of macrosomic babies was 2.3 % (103 out of 4528 deliveries). Mean birth weight of
macrosomic babies was 4.2 ± 0.31 kg whereas in the controls it was 3.2 ± 0.35 kg. Maternal weight ≥80 kg, maternal
age ranging between 30 and 39 years, multiparity, presence of diabetes mellitus, and gestational age ≥40 years,
previous history of fetal macrosomia and delivery weight ≥80 kg were significantly associated with fetal macrosomia.
Macrosomic infants were more likely to have birth asphyxia, shoulder dystocia, hypoglycemia, respiratory distress and
perinatal trauma and increased risk of death compared to controls. Maternal complications such as postpartum
hemorrhage, second degree perineal tears and prolonged labor occurred more frequently in the macrosomia group
compared to controls (p-value <0.05), while shoulder dystocia, uterine rupture and maternal death were recorded only
among the cases and none occurred in the controls.
Conclusion: Fetal macrosomia was an important cause of maternal and neonatal morbidity at Muhimbili National
Hospital. Presence of risk factors should alert the obstetrician to closely monitor these pregnancies and plan on
appropriate mode of delivery. Macrosomic neonates should be routinely screened and appropriately managed for
hypoglycemia.
Abbreviations: ABD, Assisted breech delivery; BMI, Body mass index; C/S, Caesarean section; GDM, Gestational
diabetes mellitus; IOM, Institute of Medicine; LCVE, Low cavity vacuum extraction; MNH, Muhimbili National Hospital;
MUHAS, Muhimbili University of Health and Allied Sciences; SVD, Spontaneous vertex delivery
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Background
Fetal macrosomia is common in obstetrics with prob-
lems to both the mother and the newborn. It has been
associated with significant risk of morbidity and mortal-
ity. Over the years, the trend in fetal macrosomia has
been shown to be increasing worldwide [1–3].
Several risk factors have been identified in the caus-
ation of macrosomia. These include maternal diabetes,
high pre-pregnancy Body Mass Index (BMI), excessive
weight gain during pregnancy, multiparity, male sex, par-
ental height, and prolonged gestation [3–18].
During labour, cephalo-pelvic disproportion can result
in fetal distress and difficult deliveries are frequent in this
group of infants. Maternal complications include in-
creased risk of Caesarian section, postpartum hemorrhage
and perineal lacerations [3, 8, 19]. The risk increases with
a higher birth weight of the infant [20].
Neonatal complications include birth asphyxia, birth
trauma, and hypoglycemia [8, 19, 21–25]. Polycythemia
and hypocalcemia are most often noted in infants born
to diabetic mothers. Furthermore, these infants may be at
a higher risk of obesity and diabetes later in life [26, 27].
The few studies on macrosomia have mainly focused
on the risk factors and maternal outcome. Little atten-
tion has been given to the macrosomic infant even
though they have high perinatal mortality and morbidity
rates, particularly in our setting. Hence a need was felt
to conduct this study on fetal macrosomia so as to aid in
future identification of these pregnancies, anticipate
their complications and plan on appropriate mode of
management.
Methods
This was a prospective matched case-control study con-
ducted at MNH maternity and neonatal wards in Dar es
Salaam, Tanzania. All infants with birth weight of 4000 g
or greater delivered at the labor ward during the study
period were selected as cases. The next infant of the
same sex delivered with birth weight ranging from 2500
to 3999 g was selected and served as control. Cases and
controls were matched for sex.
Three trained nurse midwives at the labor ward (one
nurse per shift) were selected and assisted in recruit-
ment of study participants. Babies were recruited within
the first hour after delivery and after written informed
consent. Recruitment of patients and sample collection
was done at any time of the day. On average two to
three cases and controls were enrolled daily.
Assuming the percentage of exposure (BMI > 28 kg/m2)
of 13.6 % in controls [8], a confidence interval of 95 %, a
power of 90 %, an assumed odds ratio of 2.5 and coeffi-
cient of correlation between cases and controls of 0.2, the
sample size was estimated using the Epi-Info version 6,
being 163 controls and 163 cases. Demographic and
medical characteristics of mother and baby were obtained
from antenatal charts and clinical notes. Infants weight,
length, and occipito-frontal circumference was measured
and entered in a standardized form.
At recruitment, a drop of capillary blood was obtained
by heel prick of the baby for random blood sugar es-
timation. This screening was repeated during the sec-
ond, fourth and sixth hour after delivery. Results were
confirmed by checking plasma glucose levels. Blood
was drawn for hematocrit, plasma calcium and glu-
cose estimation. Infants suspected to have a fracture
underwent X-ray examination for confirmation. They
were reported by an experienced radiologist. Manage-
ment was based on the standard treatment guidelines
of the unit and all recruited babies were followed-up
while in the ward until recovery and discharge or
death. Discharge was sub-classified as discharge with/
without disability.
Analysis was done using SPSS (Statistical Package for
Social Science) software version 15. Means were com-
pared by using Wilcoxon signed ranks test. Univariate
analysis of risk factors was carried out using conditional
logistic regression in order to determine strength of as-
sociation with the outcome. Multivariate conditional lo-
gistic regression analysis was carried out on variables
that were significant in the univariate analysis. Indica-
tions for caesarean section (C/S) and maternal and neo-
natal complications of fetal macrosomia were analyzed
using binary logistic regression. Odds ratio with 95 %
confidence intervals (CIs) were calculated for risk factors
and complications. A p-value of less than 0.05 was con-
sidered as statistically significant.
Results
During the study period October 2009 to March 2010,
there were a total of 4528 deliveries of which 103 had a
weight greater than or equal to 4000 g. The prevalence
of fetal macrosomia was 2.3 %.
Maternal and fetal characteristics
In the macrosomia group, mean maternal age was
29.9 years and was not significantly higher than the con-
trol group (p-value 0.05). Mean parity was significantly
greater in the macrosomia group compared to the con-
trols (2.4 vs. 1.2, p-value <0.001). Other parameters in-
cluding weight at delivery, mean height and gestational
age at delivery were also significantly higher among the
cases compared to the controls. Mean birth weight in
the macrosomia group was similar among male and fe-
male macrosomic neonates (p-value 0.3). Infants deliv-
ered by caesarean section had a greater mean birth
weight compared to those delivered vaginally (4800 vs.
4200 kg). However this was not statistically significant
(p-value 0.4). There were more males than females in
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the study population and the overall male to female ratio
was 1.5:1 (Table 1).
Maternal risk factors for fetal macrosomia
More than half of the mothers who delivered macroso-
mic infants had weight greater than 80 kg at delivery. In
comparison, 73.6 % of women who delivered normal
birth weight infants had a delivery weight less than
80 kg. Women with delivery weight greater than or
equal to 80 kg were four times more likely to deliver
macrosomic babies compared to controls (95 % CI
[2.2–9.1]).
Majority of mothers delivering macrosomic babies
were in the age group from 30 to 39 years (55.3 %); age
groups less than 30 years and greater than or equal to
40 years were not significantly associated with macroso-
mia. Multiparity was present in 89.3 % of mothers in the
macrosomia group. A significantly greater percentage
(46.7 %) of mothers in the macrosomia group had previ-
ous history of delivering macrosomic infants (compared
with 12.6 % among controls). Mothers having diabetes
mellitus were 10 times more likely to deliver a macroso-
mic baby compared to those without diabetes mellitus.
Most of the deliveries in the cases and control groups
occurred at gestational ages of 37–39 weeks (66.0 and
83.5 % respectively). However, macrosomic infants were
four times more likely than controls to be delivered at
gestational age greater than or equal to 40 weeks. None
of the mothers in our study had pregnancy that lasted
longer than 42 weeks.
When variables significant on univariate analysis were
included in the multivariate logistic regression model,
history of previous macrosomia and weight greater than
80 kg at delivery were the only maternal characteristics
that were significantly associated with increased odds for
macrosomic births (OR - 2.8 [1.1–7.2] and 2.5 [1.1–5.9],
respectively (Table 2).
Mode of delivery
The overall rate of C/S was 55.3 %. Other modes of de-
livery included spontaneous vaginal delivery (SVD),
assisted breech delivery (ABD) and low cavity vacuum
extraction (LCVE). There was no significant difference
in these modes of deliveries between the two groups.
Majority of the macrosomic infants were delivered by
C/S was (61.1 %) followed by SVD (34.0 %). The rate
of C/S was higher among cases compared to their
controls (61.1 vs. 49.5 %) but the difference was not
statistically significant (p-value 0.09). A greater per-
centage of macrosomic infants were delivered by
emergency C/S compared to controls, but the differ-
ence was not statistically significant (Table 3).
Indications for caesarean section
The commonest causes for caesarean deliveries included
previous C/S scar (35.9 %), obstructed labor (29.8 %)
and fetal distress (19.3 %). Some patients had more than
one indication for C/S. Fetal macrosomia was identified
as an indication for C/S in 20.6 % of cases, and this was
significantly greater compared to the controls (p-value
0.003). There was no significant difference in other indi-
cations for C/S between the two groups (Table 4).
Maternal complications
In the study population, 56.3 % of mothers in the macro-
somic group developed at least one complication. In
contrast, only 38.8 % of mothers in the control group
developed any complication (p <0.05). Commonest com-
plications in mothers delivering macrosomic infants in-
cluded prolonged labor (27.2 %), 2nd degree perineal
tears (22.3 %) and post-partum hemorrhage (PPH)
(17.5 %). Mothers delivering macrosomic infants were
five times more likely than the controls to develop PPH.
Uterine atony, perineal tears and uterine rupture were
the main causes of PPH. There were 3 cases of shoulder
dystocia in the macrosomia group and uterine rupture
occurred in 2 mothers in the macrosomia group (1.9 %).
There was one maternal death in the macrosomia group;
the cause of death was uterine rupture and PPH. No
death occurred in the control group (Table 5).
Neonatal complications
Neonatal complications occurred more frequently
among the macrosomic group (44.3 %) compared to the
controls (p < 0.05). The commonest neonatal complica-
tions among the macrosomic group were hypoglycemia
(22.7 %), respiratory distress (16.5 %), birth asphyxia
(14.4 %) and birth trauma (14.4 %). Mortality was






Age (yrs) 29.99 ± 5.61 28.45 ± 5.97 0.057
Parity 2.43 ± 1.8 1.22 ± 1.5 0.000
Height (m) 161.5 ± 5.59 159.7 ± 4.98 0.02
Weight at delivery (kg) 83.8 ± 13.14 73.4 ± 11.87 0.000
Gestational age (wks) 38.7 ± 1.37 38.2 ± 1.16 0.005
Birth weight (g) 4.2 ± 0.31 3.2 ± 0.35 0.000
Males 4.3 ± 0.33 3.2 ± 0.36
Females 4.2 ± 0.28 3.1 ± 0.35
Birth weight by mode of delivery
Caesarean section 4.3 ± 0.32 3.2 ± 0.37
Vaginal delivery 4.2 ± 0.29 3.1 ± 0.36
Serum calcium (mmol/L) 2.336 ± 0.15 2.334 ± 0.1882 0.93
Venous hematocrit (%) 54.9 ± 6.28 50.1 ± 5.30 0.000
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significantly higher in the macrosomia group compared
to controls (p <0.05). Main causes of death among the
cases included stillbirth (6 cases and 1 control) and birth
asphyxia. Out of the 12 macrosomic neonates who died,
three were born to diabetic mothers. The commonest
injuries were cephalhematoma and fractures (5.7 %)
followed by nerve palsy (3.1 %). They were more likely
to occur in infants delivered by SVD, ABD and LCVE.
Hypoglycemia occurred more frequently in the macroso-
mic group compared to the controls (22.7 vs. 6.9 %). In
96 % of cases, hypoglycemia occurred within 6 h of deliv-
ery. Hypoglycemia was also more frequent in infants born
to mothers without diabetes mellitus (23.5 %) compared
to those born to diabetic mothers (16.6 %); however the
difference was not significant (p-value 0.7) (Table 6).
Table 2 Analysis of maternal risk factors for fetal macrosomia
Macrosomia n (%) Controls n (%) Univariate analysis Multivariate analysis
Odds ratio [95 % CI] p-value Odds ratio [95 % CI] p-value
Weight at delivery
< 80 45 (43.7) 76 (73.7) 1a
80–89 kg 30 (29.1) 15 (14.6) 2.4 [1.2–4.8] 0.02 2.5 [1.1–5.9] 0.036
> 90 kg 28 (27.2) 12 (11.6) 2.8 [1.3–5.9] 0.009
Height
≤ 160 42 (40.8) 56 (54.4)
> 160 cm 61 (59.2) 47 (45.6) 1.8 [1.0–3.3] 0.047
Age
< 30 years 44 (42.7) 58 (56.3)
30–39 years 57 (55.3) 39 (37.9) 2.1 [1.2–3.7] 0.02 1.4 [0.6–2.9] 0.41
> 40 years 2 (1.9) 6 (5.8) 0.3 [0.7–1.6] 0.18
Parity
0–1 11 (10.7) 46 (44.7) 1 a
Para 2–4 76 (73.8) 53 (51.5) 2.0 [1.1–3.7] 0.03 1.7 [0.7–4.4] 0.24
Para ≥5 16 (15.5) 4 (3.9) 4.4 [1.3–11.9] 0.01 2.6 [0.5–13.1] 0.24
Diabetes mellitus
Yes 12 (11.6) 3 (2.9) 10.0 [1.3–78.1] 0.03 4.2 [0.5–38.1] 0.20
No 91 (88.3) 100 (97.1) 1 a
Previous macrosomia
Yes 48 (46.7) 13 (12.6) 6.3 [2.8–13.9] <0.001 2.8 [1.1–7.2] 0.031
No 46 (44.6) 43 (41.7) 1 a
Gestational age
37–39 71 (68.9) 93 (90.2) 0.4 [0.2–0.7] 1 a
40–42 32 (31.1) 10 (9.7) 4.1 [1.8–9.5] 0.001 1.9 [0.7–5.5] 0.21
areference category








Vaginal delivery 40 (38.9) 52 (50.5) 92 (44.6)
SVD 35 (34.0) 48 (46.6) 83 (40.3) 0.52
ABD 4 (3.9) 3 (2.9) 7 (3.4)
LCVE 1 (1.0) 1 (1.0) 2 (1.0)
C/S 63 (61.1) 51 (49.5) 114 (55.3) 0.09*
Emergency 35 (34.0) 25 (24.3) 60 (29.1) 0.48
Elective 28 (27.2) 26 (25.2) 54 (26.2) 1
Total 103 (50) 103 (50) 206 (100)
*p-value calculated to determine difference between caesarean and
vaginal deliveries
Table 4 Indications for caesarean section
Macrosomia Controls Total N (%) p-value
Fetal macrosomia 13 (20.6) 1 (1.9) 14 (12.3) 0.003
Fetal distress 11 (17.5) 11 (21.5) 22 (19.3) 0.7
Obstructed labor 22 (34.9) 12 (23.5) 34 (29.8) 0.3
Previous C/S scar 19 (30.2) 22 (43.1) 41 (35.9) 0.2
Uterine rupture 2 (3.2) 0 2 (1.7)
Cephalo-pelvic disproportion 6 (9.5) 5 (9.8) 11 (9.6) 0.07
Total 63 (55.3) 51 (44.7) 114 (100)
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Neonatal complications of macrosomic babies by mode
of delivery
A greater proportion of neonates delivered vaginally
compared to those delivered by C/S died (12.5 vs. 7.9 %);
however this difference was not significant.
Other complications such as hypoglycemia, respiratory
distress and birth asphyxia occurred more frequently in
the caesarean section group compared to those delivered
vaginally. Compared to those delivered vaginally, a sig-
nificantly higher percentage of neonates in the caesarean
group developed respiratory distress. None of the neo-
nates delivered by C/S sustained birth trauma whereas
35 % of infants delivered vaginally sustained birth
trauma (p-value <0.001) (Table 7).
Discussion
The prevalence of fetal macrosomia in our study was
2.3 %. Other studies in Africa have reported prevalence
of 3.4 % in South Africa [17] and 3.5 % in Nigeria [18].
This low prevalence may be explained by the lower
pre-pregnancy weight and low socio-economic status in
our population.
Maternal risk factors
There was a strong association between fetal macroso-
mia and maternal age greater than 30 years. This finding
was similar to that seen in South Africa by Essel et al.
[17]. This may be due to the fact that increasing mater-
nal age may have an effect on maternal metabolism
thereby increasing the growth velocity in the fetus.





p-value Odds ratio [95 % CI]
Post partum hemorrhage (PPH)
Yes 18 (17.5) 4 (3.9) 0.0015 5.24 [1.71, 16.09]
No 85 (82.5) 99 (96.1) 1
Prolonged labor
Yes 28 (27.2) 14 (13.6) 0.02 2.37 [1.17, 4.83]
No 75 (72.8) 89 (86.4) 1
Uterine rupture
Yes 2 (1.9) 0 (0.0)
No 101 (98.1) 103 (100)
2nd degree tear
Yes 23 (22.3) 6 (5.8) 0.001 4.65 [1.80, 11.97]
No 80 (77.7) 97 (94.2) 1
Shoulder dystocia
Yes 3 (2.9) 0 (0.0)
No 100 (97.1) 103 (100)
Maternal death
Yes 1 (1.0) 0 (0.0)
No 102 (99.0) 103 (100)





p-value Odds ratio [95 % CI]
Birth asphyxia
Yes 14 (14.4) 3 (3.0) 0.004 5.51 [1.53, 19.83]
No 83 (85.6) 98 (97.0) 1
Respiratory distress
Yes 16 (16.5) 6 (5.9) 0.03 3.13 [1.17, 8.37]
No 81 (83.5) 95 (94.1) 1
Hypoglycemia
Yes 22 (22.7) 7 (6.9) 0.002 3.94 [1.60, 9.72]
No 75 (77.3) 94 (93.1) 1
Hypocalcemia
Yes 1 (1.0) 1 (1.0) 0.7
No 96 (99.0) 100 (99.0)
Polycythemia
Yes 3 (3.1) 0 (0.0) 0.1
No 94 (96.9) 101 (100)
Death
Yes 10 (9.7) 2 (1.9) 0.03 5.4 [1.16, 25.43]
No 93 (90.3) 101 (98.1) 1
Birth trauma
Yes 14 (14.4) 1 (1.0) 0.0003 16.87 [2.17, 130.97]
No 83 (85.6) 100 (99.0) 1










Yes 5 (7.9) 5 (12.5) 10 (97.1) 0.44
No 58 (92.1) 35 (87.5) 93 (90.3)
Hypoglycemia
Yes 16 (25.4) 6 (15) 22 (21.4) 0.2
No 47 (74.6) 34 (77.5) 81 (78.6)
Birth trauma
Yes 0 14 (35) 14 (13.5) 0.0001
No 63 (100) 26 (65) 89 (86.4)
Birth asphyxia
Yes 10 (15.9) 4 (10) 14 (13.6) 0.39
No 53 (84.1) 36 (90) 89 (86.4)
Respiratory distress
Yes 15 (23.8) 1 (2.5) 16 (15.5) 0.0003
No 48 (80) 39 (97.5) 87 (84.5)
Total 63 (61.2) 40 (38.8) 103 (100)
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Pregnancy duration greater than 40 weeks was also sig-
nificantly associated with fetal macrosomia. This finding
parallels that observed by Cheng et al. [12]. Previous his-
tory of macrosomia was significantly associated with re-
currence. A similar finding was noted in other studies
[3, 7, 17, 18, 28]. This effect remains even after control-
ling for derangement in glucose metabolism [29]. Recur-
rence of fetal macrosomia may be due to greater
maternal BMI at the time of conception, excessive
weight gain between pregnancies as well as weight gain
during pregnancy [30].
A history of diabetes mellitus (pre-existing or gesta-
tional) occurred more frequently among the cases com-
pared to the controls. The finding of 11.6 % was much
higher compared to 7.1 % in seen in Ibadan, Nigeria
[18]. Diabetes in this group may be associated with obes-
ity and thus greater insulin resistance, resulting in in-
creased glucose availability to the fetus. Moreover, even
in mothers without gestational diabetes mellitus (GDM)
minor abnormalities in glucose metabolism during early
and late gestation has been shown to increase the risk of
fetal overgrowth [29]. Multiparity was present in 89.3 %
of mothers delivering macrosomic infant. The finding
was in keeping with other studies [8, 17]. It is speculated
that increased parity associated with decreased insulin
sensitivity results in greater amount of glucose being
available for placental glucose transport and thus greater
adipose tissue deposition in the fetus [31].
Mothers with a weight at delivery greater than or
equal to 80 kg were more likely than their controls to
deliver a macrosomic infant. Other authors have found
that weight greater than or equal to 90 kg to be signifi-
cantly associated with fetal macrosomia [17, 31]. Previ-
ous reports have shown that increased pre-pregnancy
BMI as well as weight gain during pregnancy above the
Institute of Medicine (IOM) guidelines to be associated
with macrosomia [32]. It was not possible to determine
whether this association existed in our population since
majority of the mothers booked late during pregnancy
and were not aware of their pre-pregnancy weight.
The high male to female ratio in the macrosomic
group has been reported by other studies [7, 8, 18].
Ricart et al. showed that maternal glucose tolerance sta-
tus was a significant predictor of fetal macrosomia in
male but not in female neonates [33]. This may be ex-
plained by sexual dimorphism for insulin sensitivity,
growth hormone-insulin growth factor 1 axis and cyto-
kines. In addition, a prolongation of pregnancy could in-
crease the exposure of the fetus to higher levels of
glucose, insulin and different metabolic alterations if
gestational diabetes is present. Catalano et al. also
showed that average birth weight was significantly greater
in males than females. This was attributed to increased
neonatal fat free mass in males [31]. In our study,
increased mean birth weight in males compared to fe-
males was not significant and could be due to chance.
Maternal outcomes of fetal macrosomia
Postpartum hemorrhage, second degree perineal lacera-
tions and prolonged labor were significant maternal
complications in the macrosomia group. This was simi-
lar to findings noted by other authors [4, 8, 19]. The in-
creased risk of PPH in this group may be due to perineal
tears and prolonged labor resulting in uterine atony [28].
Moreover, uterine rupture occurred in two mothers de-
livering macrosomic infants and therefore been a cause
of PPH in our study. There was one maternal death in
the macrosomia group and this was due to uterine rup-
ture and PPH. The maternal mortality rate of 971 per
100,000 was lower than that observed by Kamanu et al.
[8]. The cause of death was however similar to that ob-
served in their study and was due to an avoidable cause.
Sixty one percent of macrosomic babies were delivered
by C/S in our study. This rate is four times higher com-
pared to other studies [8, 19]. Although more infants
were born by caesarean delivery in the macrosomia
group, the difference was not significant compared to
controls. Common causes of emergency C/S were
obstructed labor and fetal distress and were not signifi-
cantly different among cases and controls. This may be
attributed by the fact that the study was conducted at a
referral hospital and therefore a greater possibility of
labor complications which necessitated emergency deliv-
ery by C/S in both groups. In our study, only 20.6 % of
macrosomic infants delivered by C/S were identified by
clinical examination. This highlights a need for identifi-
cation of additional methods to identify macrosomic in-
fants and determine appropriate mode of delivery prior
to developing complications.
Shoulder dystocia occurred in 3 mothers delivering
macrosomic infants and was associated with brachial
plexus injuries. Similar to a study done by Iffy et al. [34]
all the cases occurred with vaginal delivery. This sug-
gests that shoulder dystocia is an important cause of
birth related injuries particularly when macrosomic neo-
nates are delivered vaginally and highlights a need of
awareness and training of birth attendants on emergency
management of shoulder dystocia.
Neonatal outcomes of fetal macrosomia
Similar to other studies, macrosomia was shown to be
associated with adverse neonatal outcomes [8, 21, 35].
Birth asphyxia was five times more likely in the study
group compared to controls. Commonest causes were
due to obstructed labor and fetal distress. Compared to
infants delivered vaginally, a greater proportion of in-
fants delivered by C/S had birth asphyxia. Delays in
management of labor complications results in adverse
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pregnancy outcomes [36]. This emphasizes the need for
continuous monitoring, identification of labor complica-
tions and avoiding delays in undertaking caesarean
section so as to reduce complications such as birth as-
phyxia. Respiratory distress was also a significant neo-
natal complication among the macrosomia group and
together with birth asphyxia was an important cause of
admission to the neonatal ward. In this study, respiratory
distress occurred more frequently in neonates delivered
by C/S compared to those delivered vaginally. Das et al.
found a similarly high frequency of respiratory distress
in the macrosomia group which may be attributed to in-
fluence of increased caesarean deliveries and maternal
diabetes on lung maturity [37]. Thus, the decision to opt
for delivering macrosomic babies by C/S may have to be
weighed against outcomes such as respiratory distress
and increased admissions to the neonatal unit.
Birth trauma was greater in the macrosomia group
compared to controls. Similar to other studies [8, 28, 34],
the complication occurred only in neonates delivered vagi-
nally. This finding suggests that complications such as
birth trauma can be prevented by opting for C/S.
Hypoglycemia occurred in 22.7 % of macrosomic neo-
nates. This was higher than that observed by Oral et al.
[28]. Contrary to their findings, our study did not find
any association of hypoglycemia with maternal diabetes
status or birth weight greater than 4500 g. Though not
significant, it is of concern that infants born to non-
diabetic mothers developed hypoglycemia. This may be
due to minor derangements in maternal glucose metab-
olism and therefore suggest that macrosomic infants re-
quire close monitoring for hypoglycemia regardless of
maternal diabetic status. Not unexpectedly, most cases
of hypoglycemia occurred in infants born by caesarean
section. This may have been due to delay in initiation of
feeding and intravenous dextrose in these neonates.
Similar to a study by Oral et al., there was no signifi-
cant association between macrosomia with polycythemia
and hypocalcemia [28]. All the cases that developed
these outcomes were asymptomatic and therefore no
treatment was given. Mortality was significantly associ-
ated with macrosomia as has been previously noted by
other authors [3, 8]. Contrary to the study by Zhang et
al. [21], most deaths occurred in macrosomic neonates
in the weight range of 4000–4499 g compared to those
weighing 4500 g. This may be due to differences in study
design as well as differences in study population. Deaths
due to birth asphyxia may have been preventable had
the underlying problem been anticipated earlier and the
mode of delivery been more planned.
Study limitations
Due to non-availability of results of oral glucose toler-
ance test results during pregnancy some mothers with
impaired glucose tolerance during pregnancy may have
been missed. Diagnostic bias was minimized by measur-
ing random blood sugar levels of all mothers in the
study population. Only those with a previously docu-
mented history of diabetes mellitus or with abnormal
random blood glucose readings were classified as having
diabetes mellitus.
Majority of the mothers booked during the second or
third trimester of pregnancy and it was not possible to
measure the total weight gain during pregnancy. As a
result, only weight measured at time of delivery was
recorded.
Sixty three percent of the total sample size was
reached and as a result reduced the power of the study
to 80 %. This power is within acceptable value given the
time limitations. Increasing the number of controls per
case could have been used to increase the study power.
Conclusion
The prevalence of fetal macrosomia at MNH was 2.3 %
and an important cause of maternal and neonatal mor-
bidity. Maternal risk factors include multiparity, previous
history of macrosomia, presence of diabetes mellitus,
gestational age of 40 weeks and above, delivery weight
greater than or equal to 80 kg and maternal age ranging
between 30 and 39 years. Complications included PPH,
2nd degree perineal lacerations, uterine rupture, and
prolonged labor and maternal death. The neonatal com-
plications included birth asphyxia, respiratory distress,
hypoglycemia and death. We suggest that mothers
should be screened using risk factors identified and be
treated as a high risk delivery, with planned delivery and
after care.
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